Y-mAbs Therapeutics Inc.

11/04/2024 | Press release | Distributed by Public on 11/04/2024 07:30

Y mAbs and Nobelpharma Announce Exclusive License and Distribution Agreement for DANYELZA® (naxitamab gqgk) in Japan

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.